Castle biosciences announces publication of clinical validation and utility data for decisiondx® diffdx™-melanoma for suspicious pigmented lesions

Friendswood, texas--(business wire)---- $cstl #castlebiosciences--castle biosciences announces publication of clinical validation and utility data for decisiondx® diffdx™-melanoma for suspicious pigmented lesions.
CSTL Ratings Summary
CSTL Quant Ranking